| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-07 |